免疫組織化学の市場規模、シェア、成長分析、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

世界の免疫組織化学の市場規模は、2022年に約29億米ドルとなり、予測期間（2024年～2031年）のCAGRは7.4%で、2023年の31億米ドルから上昇し、2031年までには55億米ドルに達すると予測されています。

世界の免疫組織化学（IHC）市場は、広範なライフサイエンスおよび診断薬市場の中で急成長している分野であり、主にがんやその他の慢性疾患の有病率の増加がその原動力となっています。組織抗原やバイオマーカーを同定する重要な技術であるIHCは、がんの診断やモニタリング、標的治療の実現、疾患経路の解明などに広く利用されています。個別化医療が進展し、疾患の早期発見が重視されるようになるにつれて、IHC技術の需要は急増すると予想されます。同市場は、大手企業による継続的な研究開発投資、新規バイオマーカーの採用、診断精度と効率を高める自動化IHC装置などの恩恵を受けています。市場は、製品タイプ（抗体、試薬、機器、キット）、用途（診断、薬剤検査、研究）、エンドユーザー（病院、診断ラボ、研究機関）で区分されます。北米は強固なヘルスケアインフラ、高いがん罹患率、広範な研究開発活動によりリードしています。次いで欧州とアジア太平洋が続き、後者は医療費の増加、患者層の拡大、高度な診断技術に対する意識の高まりにより、急成長が予測されています。世界のIHC市場は競争が激しく、F. Hoffmann-La Roche AG、Danaher Corporation、Agilent Technologies、Thermo Fisher Scientificなどの主要企業が技術革新と市場拡大を牽引しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要展望
• 供給需要動向分析
• セグメント別機会分析

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 市場のエコシステム
• バリューチェーン分析
• 価格分析
• 特許分析
• ケーススタディ分析
• 技術分析
• 規制分析
• サプライチェーン分析
• イノベーションマトリクス
• 主要な投資分析
• 主要な成功要因
• 競合の程度

免疫組織化学市場：製品別

• 市場概要
• 抗体
  • タイプ
  • 一次抗体
  • 二次抗体
  • クローン性
  • モノクローナル抗体
  • ポリクローナル抗体
  • 試薬
  • 組織学的染色
  • ブロッキング血清・試薬
  • 発色基質
  • 固定試薬
  • 有機溶剤
  • タンパク質分解酵素
  • 希釈剤
  • その他の試薬（抗原賦活化溶液、安定剤、コントロール、マウント溶液）
  • 装置
  • スライド染色システム
  • 組織処理システム
  • スライドスキャナ
  • その他の機器（デジタル病理学システム、自動カバースリッパなどの組織学機器、視覚化機器（明視野、蛍光顕微鏡）、ミクロトーム、パラフィンディスペンサー、スライドラベラー、組織マイクロアレイ）
  • キット
  • 人間免疫組織化学キット
  • 動物免疫組織化学キット

免疫組織化学市場：用途別

• 市場概要
• 診断用途
  • がん
  • 感染症
  • 自己免疫疾患
  • 腎臓疾患
  • 神経疾患
  • その他の疾患（眼科、心臓血管、皮膚科、歯科の疾患）
• 研究用途
  • 医薬品の開発と試験
  • その他の研究用途（幹細胞研究・発生生物学）
  • 法医学用途

免疫組織化学市場：エンドユーザー別

• 市場概要
• 病院・診断研究所
• 学術機関・医薬品開発業務受託機関（CRO）
• その他のエンドユーザー（製薬会社、バイオ製薬会社、法医学研究所）

免疫組織化学市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Agilent Technologies, Inc.
• PHC Holdings Corporation
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Becton, Dickinson and Company
• Takara Bio Inc.
• Enzo Biochem Inc.
• Sino Biological, Inc.
• Sakura Finetek Japan Co., Ltd.
• Cell Signaling Technology, Inc.
• BIO SB
• Miltenyi Biotec
• OriGene Technologies, Inc.
• EagleBio
• Biocare Medical, LLC
• Elabscience Bionovation Inc.
• BioGenex
• Diagnostic BioSystems Inc.
• Histo-Line Laboratories
• Rockland Immunochemicals, Inc.
• Candor Bioscience GmbH
• Genemed Biotechnologies, Inc.

Global Immunohistochemistry Market size was valued at around 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024-2031).

The Global Immunohistochemistry (IHC) Market is a rapidly growing sector within the broader life sciences and diagnostics markets, primarily driven by the increasing prevalence of cancer and other chronic diseases. IHC, a key technique for identifying tissue antigens and biomarkers, is widely used for diagnosing and monitoring cancer, enabling targeted therapy, and understanding disease pathways. With advancements in personalized medicine and a rising emphasis on early disease detection, the demand for IHC techniques is expected to surge. The market benefits from continuous R&D investments by major players, the introduction of novel biomarkers, and automated IHC instruments, which enhance diagnostic accuracy and efficiency. The market is segmented by product type (antibodies, reagents, equipment, kits), application (diagnostics, drug testing, research), and end-users (hospitals, diagnostic labs, research institutions). North America leads due to robust healthcare infrastructure, high cancer prevalence, and extensive R&D activities. Europe and Asia-Pacific follow, with the latter projected to witness the fastest growth due to rising healthcare expenditure, expanding patient pool, and increasing awareness of advanced diagnostic techniques. The global IHC market is highly competitive, with key players like F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, and Thermo Fisher Scientific driving innovation and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segmental Analysis

Global Immunohistochemistry Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits). Based on Application, the market is segmented into Application Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology), and Forensic applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Immunohistochemistry Market

One of the major drivers of the Global Immunohistochemistry Market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with millions of new cases diagnosed annually. Immunohistochemistry is a vital tool in oncology, providing crucial information for the diagnosis, prognosis, and selection of targeted therapies. With the increasing number of cancer cases, the demand for accurate and reliable diagnostic methods has surged, pushing the adoption of IHC techniques in clinical settings. Moreover, advancements in IHC, such as the development of new antibodies and detection systems, enhance the precision of cancer diagnostics, leading to better patient management and outcomes. As personalized medicine continues to gain traction, the role of IHC in selecting appropriate therapeutic strategies further reinforces its market growth.

Restraints in the Global Immunohistochemistry Market

The high cost of immunohistochemistry instruments and reagents is a significant restraint to the market's growth. IHC requires sophisticated equipment, including automated staining systems and advanced microscopes, which involve substantial capital investment. Additionally, the cost of reagents, such as antibodies and detection kits, can be high, especially when multiple tests are needed for comprehensive diagnosis. This makes IHC relatively expensive compared to other diagnostic techniques, limiting its adoption in regions with limited healthcare budgets or underdeveloped healthcare infrastructure. In emerging economies, the cost burden can be a significant barrier for smaller hospitals, clinics, and diagnostic labs that lack the financial resources to invest in advanced diagnostic technologies. Furthermore, the ongoing maintenance and operational costs associated with IHC instruments add to the overall expenses, creating a financial constraint for healthcare providers.

Market Trends of the Global Immunohistochemistry Market

The integration of automation and digital pathology in immunohistochemistry represents a significant trend shaping the market. Automated IHC instruments offer several advantages, such as reduced manual errors, enhanced reproducibility, and faster turnaround times, which are crucial for accurate and timely diagnosis. This trend is particularly important in high-throughput settings like hospitals and diagnostic laboratories. Furthermore, the integration of digital pathology with IHC allows for the digitization of slides, enabling remote analysis, collaboration, and AI-based image analysis. This advancement not only enhances diagnostic accuracy but also facilitates the efficient storage and retrieval of histopathological data, improving overall workflow efficiency. Leading market players are increasingly investing in developing automated IHC platforms integrated with digital pathology solutions, anticipating a robust adoption rate in the coming years due to their potential to transform pathology practices globally.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Study Analysis
• Technology Analysis
• Regulatory Analysis
• Supply Chain Analysis
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Immunohistochemistry Market by Product

• Market Overview
• Antibodies
  • Type
  • Primary antibodies
  • Secondary antibodies
  • clonality
  • Monoclonal antibodies
  • Polyclonal antibodies
  • Reagents
  • Histological Stains
  • Blocking Sera and Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
  • Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)
  • Equipment
  • Slide-staining Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)
  • Kits
  • Human Immunohistochemistry Kits
  • Animal Immunohistochemistry Kits

Immunohistochemistry Market by Application

• Market Overview
• Diagnostic applications
  • Cancer
  • Infectious diseases
  • Autoimmune diseases
  • Nephrological diseases
  • Neurological diseases
  • Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases)
• Research applications
  • Drug Development and Testing
  • Other research applications (Stem Cell Research And Developmental Biology)
  • Forensic applications

Immunohistochemistry Market by End User

• Market Overview
• Hospitals & Diagnostic Laboratories
• Academic Institutions & Contract Research Organizations (CROs)
• Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)

Immunohistochemistry Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek Japan Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EagleBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elabscience Bionovation Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostic BioSystems Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Histo-Line Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Candor Bioscience GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genemed Biotechnologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments